ArticleScience advances2025
Mapping neurophysiological and molecular profiles of heterogeneity and homogeneity in schizophrenia-bipolar disorder.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The heterogeneity of psychotic disorders leads to instability in subjectively defined diagnoses. This study used a machine learning framework termed common orthogonal basis extraction (COBE) to decompose electroencephalography-based functional connectivity (FC) in patients with psychotic bipolar disorder (PBD), schizophrenia (SCZ), and schizoaffective disorder (SAD) into individualized and shared subspaces. The results demonstrated that individualized FCs captured disease heterogeneity and predicted symptom severity more accurately than raw FCs, while shared FCs revealed diagnosis-specific abnormalities and achieved an accuracy of 79.30% in differentiating PBD, SCZ, and SAD. Furthermore, molecular decoding implicated regionally selective serotonin systems and astrocytes in the neurobiological differences among disorders, suggesting disorder-specific pharmacological targets. Critically, these findings were replicated in an independent cohort, confirming the effectiveness of the COBE framework in mining neurophysiological and molecular profiles of schizophrenia-bipolar disorder. These findings advance mechanistic understanding of psychotic disorders and offer a promising avenue toward objective, clinically relevant tools for psychotic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.